Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
ERAS

ERAS - Erasca, Inc. Stock Price, Fair Value and News

$11.97-1.30 (-9.80%)
Market Closed

Price Targets

ERAS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ERAS Price Action

Last 7 days

-6.8%

Last 30 days

9.8%

Last 90 days

-22.6%

Trailing 12 Months

662.4%

ERAS RSI Chart

ERAS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ERAS Valuation

Market Cap

3.7B

Price/Earnings (Trailing)

-13.43

EV/EBITDA

-30.22

Price/Free Cashflow

-40.72

MarketCap/EBT

-29.87

ERAS Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

ERAS Fundamentals

ERAS Earnings

Earnings (TTM)

-277.0M

Earnings Growth (Yr)

-492.39%

Earnings Growth (Qtr)

-530.55%

ERAS Profitability

Return on Equity

-70.39%

Return on Assets

-60.06%

Free Cashflow Yield

-2.46%

ERAS Investor Care

Shares Dilution (1Y)

9.72%

Diluted EPS (TTM)

-0.93

About Erasca, Inc.

ERAS
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.
 CEO
 WEBSITEerasca.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES129

Erasca, Inc. Frequently Asked Questions

ERAS is the stock ticker symbol of Erasca, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Jun 05 2026, market cap of Erasca, Inc. is 3.72 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.